91133-71-0 Usage
General Description
4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER is a chemical compound with the molecular formula C11H13NO3. It is commonly used as an intermediate in the synthesis of pharmaceutical drugs and organic compounds. 4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER is a methyl ester derivative of 4-acetamidobenzoic acid, and it is often used in the production of anti-inflammatory and analgesic drugs. It is also used in the synthesis of various organic compounds and can be found in some cosmetic and personal care products. 4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER is a white crystalline solid with a molecular weight of 207.23 g/mol. It is important to handle this compound with caution, as it may cause irritation to the skin, eyes, and respiratory system.
Check Digit Verification of cas no
The CAS Registry Mumber 91133-71-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,3 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 91133-71:
(7*9)+(6*1)+(5*1)+(4*3)+(3*3)+(2*7)+(1*1)=110
110 % 10 = 0
So 91133-71-0 is a valid CAS Registry Number.
91133-71-0Relevant articles and documents
FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES
-
, (2021/02/25)
The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.
